Related Experiment Video
Updated: Mar 8, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
Metoclopramide as intermittent and continuous infusions in critically ill patients: a pilot randomized clinical trial
Masoume Malekolkottab1, Hossein Khalili1, Mostafa Mohammadi2
1Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Aim:
Metoclopramide is commonly used as a prokinetic agent in critically ill patients with enteral feeding intolerance. In this study, noninferiority of metoclopramide as intermittent versus continuous infusion was examined in critically ill patients with enteral feeding intolerance.
Methods:
Forty critically ill adults patients were assigned to receive metoclopramide as either intermittent (10 mg every 6 h) or continuous (2 mg/h) infusion. Frequency of feeding intolerance and adverse effects of metoclopramide were assessed during 7 days of study.
Results:
Number of patients with feeding intolerance during different times of the course was not different between the groups. Although not statistically significant, diarrhea and cardiac rhythm were more common in continuous than intermittent infusion group.
Conclusion:
Continuous and intermittent infusions of metoclopramide showed equivalent effectiveness in critically ill patients.
More Related Videos
08:44Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema
Published on: September 1, 2016
09:17Use of a Central Venous Line for Fluids, Drugs and Nutrient Administration in a Mouse Model of Critical Illness
Published on: May 2, 2017
Related Concept Videos
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
IV Infusion to Oral Dosing: Conversion Methods
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Oral Drug Delivery Systems: Continuous-Release Systems
Continuous Renal Replacement Therapy
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists